Sign In

Alex Menys

CEO at Motilent | Ph.D and Honorary Associate Prof. at UCL

Alex Menys is a dedicated professional with a primary focus on measuring treatment response in Crohn's Disease and is actively engaged in diverse gastro-related projects, encompassing conditions like constipation, gastroparesis, IBS, and other gastrointestinal diseases.

He is particularly enthusiastic about the advancements in non-invasive gastroenterology utilizing technologies such as MRI, ultrasound, and capsule endoscopy. Alex Menys is the founder of Motilent, a platform aimed at bridging the gap between technology and healthcare, while maintaining a profound interest in collaborative research efforts with global partners.

His core beliefs revolve around the significance of Real World Evidence in evaluating new technologies, understanding healthcare processes before implementing innovations, acknowledging that change in healthcare requires close collaboration with professionals, and recognizing that innovation and adoption in healthcare are long-term endeavors.

Alex Menys is a highly qualified individual, holding a Doctor of Philosophy (PhD) in MR Physiology, with a specialization in Medical Image Computing and Medical image post-processing, along with studies in Experimental Medicine focusing on Antibody engineering, and a background in Biochemistry from UCL and King's College London.

With a rich professional background, Alex Menys has served in various roles including as a Former Honorary Associate Professor at UCL, Former CEO at Motilent, Former Non Executive Director at FEEDBACK PLC, and as a Former Postdoctoral Fellow at UCL.

Alex Menys
Add to my network

Location

London, England, United Kingdom